My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Aveo Pharmaceuticals (AVEO)
AVEO nasdaq
United States
AVEO Pharma

AVEO Pharma Stock Analysis & Ratings

AVEO Pharma Stock Analysis Overview

Smart Score
Learn more about TipRanks Smart Score
The AVEO Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart


AVEO Stock Stats

Previous Close$6.45
Bid5.95 x 500
Ask7.03 x 100
Today’s Range$6.29 - $6.545
52-Week Range$4.95 - $18.24
Average Volume416.18K
Market Cap$216.56M
P/E Ratio-3.3
Earnings DateNov 11, 2021

Company Description

Aveo Pharmaceuticals

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
Michael P. Bailey
30 Winter Street, Boston, MA, 02108, US


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

AVEO Pharma News


What was AVEO Pharma’s price range in the past 12 months?
AVEO Pharma lowest stock price was $4.95 and its highest was $18.24 in the past 12 months.
    What is AVEO Pharma’s market cap?
    AVEO Pharma’s market cap is $216.56M.
      What is AVEO Pharma’s price target?
      The average price target for AVEO Pharma is $20.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $24.00 ,the lowest forecast is $18.00. The average price target represents 222.70% Increase from the current price of $6.3.
        What do analysts say about AVEO Pharma?
        AVEO Pharma’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is AVEO Pharma’s upcoming earnings report date?
          AVEO Pharma’s upcoming earnings report date is Nov 11, 2021 which is in 23 days.
            How were AVEO Pharma’s earnings last quarter?
            AVEO Pharma released its earnings results on Aug 05, 2021. The company reported -$0.396 earnings per share for the quarter, beating the consensus estimate of -$0.498 by $0.102.
              Is AVEO Pharma overvalued?
              According to Wall Street analysts AVEO Pharma’s price is currently Undervalued.
                Does AVEO Pharma pay dividends?
                AVEO Pharma does not currently pay dividends.
                What is AVEO Pharma’s EPS estimate?
                AVEO Pharma’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does AVEO Pharma have?
                AVEO Pharma has 34,370,000 shares outstanding.
                  What happened to AVEO Pharma’s price movement after its last earnings report?
                  AVEO Pharma reported an EPS of -$0.396 in its last earnings report, beating expectations of -$0.498. Following the earnings report the stock price went up 13.55%.
                    Which hedge fund is a major shareholder of AVEO Pharma?
                    Among the largest hedge funds holding AVEO Pharma’s share is Clough Capital Partners L P. It holds AVEO Pharma’s shares valued at 691K.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis